Recent Blog Posts
Pharmacoequity: Improving Representation in Medicine and Fairness in Care
Access to safe and effective medicines is a cornerstone of modern healthcare. Yet, not everyone enjoys equal benefit from the advancements in pharmaceutical research and innovation. Pharmacoequity is the principle that every individual, regardless of race, ethnicity,...
The Microbiome and Cancer: What Do We Know?
Insights from research and an interview with Dr Jennifer Wargo, MD, University of Texas M.D. Anderson Cancer Center, as featured in a recent JAMA interview. The human body is home to trillions of microbes - bacteria, viruses, fungi, and other microorganisms - that...
Pharmalys at the Mastercard Foundation Networking Event for Employers and Associates
On 26 June 2025, the Mastercard Foundation held a networking event for employers and associates at Noom Hotel in Dakar, Senegal. The event marked the end of the programme’s final evaluation phase and brought together associates, line managers, and stakeholders to...
A spotlight on the Pharmalys Regulatory Affairs Unit
As clinical research expands rapidly across the African continent, the demand for strategic and locally grounded regulatory support is becoming more critical than ever. From clinical trial start-up to post-marketing activities, effective regulatory oversight is key to...
Pharmalys at the EDCTP Forum, Kigali 2025
Pharmalys participated as an exhibitor at the EDCTP Forum 2025, held from 15 to 20 June 2025 in Kigali, Rwanda. The event brought together a diverse community of stakeholders, providing a unique platform for collaboration, learning, and visibility. This year’s theme,...
July 2025 Newsletter: Female Genital Mutilation, Project Management Training, Pharmalys Regulatory Affairs and Study Start-Up Services
Female Genital Mutilation/Cutting: Understanding the Ongoing Global Crisis Female genital mutilation (FGM) is defined by the World Health Organization (WHO) as ‘all procedures which intentionally alter or damage the external female genitalia organs for non-medical...
Highlights from the Pharmalys Voice meeting, June 2025
On June 26, 2025, Pharmalys held its second Pharmalys Voice meeting of the year, bringing together colleagues from across the company in a dynamic and interactive virtual gathering. The meeting was marked by thoughtful presentations, engaging discussions, and a sense...
Female Genital Mutilation/Cutting: Understanding the Ongoing Global Crisis
Female genital mutilation (FGM) is defined by the World Health Organization (WHO) as ‘all procedures which intentionally alter or damage the external female genitalia organs for non-medical reasons and which have no benefit for the health of young girls and women.’...
Pharmalys Supports #Red4Research: Celebrating the People Behind Groundbreaking Health Advances
At Pharmalys, we proudly stand alongside the global community championing health and social care research through the #Red4Research initiative. This movement honours the countless individuals, research participants, patients, healthcare professionals, volunteers, and...
Advancing African Clinical Research Capacity: Pharmalys at TCIS Africa 2025
Pharmalys was pleased to participate in TCIS Africa 2025, an important gathering of clinical research professionals from across the continent. The event underscored the progress being made in Africa’s research landscape, while also highlighting the essential work...